文献速递胃肠外科

单孔腹腔镜结肠癌手术的长期肿瘤学结局

Long-term oncologic outcomes of single-incision laparoscopic surgery for colon cancer.
PubMed 文献 · Surg Endosc · 2021-08-31

该研究基于2009年7月至2014年9月共641例连续接受腹腔镜结肠癌手术的患者,经倾向评分匹配后纳入300例(每组150例),比较单孔腹腔镜手术(SILS)与传统腹腔镜手术(CLS)的围手术期及长期结局。结果显示SILS组总切口长度更短、术后疼痛更轻,切口疝发生率相似(2.7% vs 3.3%);7年总生存率分别为92.7%与94%(p=0.673),无病生存率分别为85.3%与84.7%(p=0.688)。结论认为SILS在围手术期及长期肿瘤学结局方面是安全的,可作为特定结肠癌患者的合理选择。

要点

  • SILS与CLS的7年总生存率(92.7% vs 94%)和无病生存率(85.3% vs 84.7%)无显著差异。
  • SILS组总切口长度更短、术后疼痛更轻,切口疝发生率相似(2.7% vs 3.3%)。
  • SILS可作为经过选择的结肠癌患者的合理手术选择。

核心结论

  • 与CLS相比,SILS用于结肠癌在围手术期及长期肿瘤学结局方面是安全的,可作为特定患者的合理治疗选择。

研究设计与样本

  • 回顾性队列研究,2009年7月至2014年9月共641例连续接受腹腔镜结肠癌手术的患者,经倾向评分匹配后纳入300例(每组150例)进行分析。

主要发现

  • SILS组平均总切口长度更短、术后疼痛更轻,切口疝发生率与CLS组相似(2.7% vs 3.3%)。
  • SILS组与CLS组的7年总生存率分别为92.7%与94%(p=0.673)。
  • SILS组与CLS组的7年无病生存率分别为85.3%与84.7%(p=0.688)。

临床怎么用

  • 对于经过选择的结肠癌患者,SILS可作为与传统腹腔镜手术等效的微创术式选项。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Studies find similar perioperative outcomes between single-incision laparoscopic surgery (SILS) and conventional laparoscopic surgery (CLS) for colon cancer. However, few have reported long-term outcomes of SILS versus CLS. We aimed to compare long-term postoperative and oncologic outcomes as well as perioperative outcomes between SILS and CLS for colon cancer. METHODS: A total of 641 consecutive patients who underwent laparoscopic surgery for colon cancer from July 2009 to September 2014 were eligible for the study. Data from 300 of these patients were used for analysis after propensity score-matching (n = 150 per group). Variables associated with short- and long-term outcomes were analyzed. RESULTS: The SILS group had a shorter mean total incision length, less postoperative pain, and a similar mean rate of incisional hernia (2.7% versus 3.3%) compared with the CLS group. The 7-year overall and disease-free survival rates were 92.7% versus 94% (p = 0.673) and 85.3% versus 84.7% (p = 0.688) in the SILS and CLS groups, respectively. CONCLUSIONS: Compared with CLS, SILS for colon cancer appeared to be safe in terms of perioperative and long-term postoperative and oncologic outcomes. The results suggested that SILS is a reasonable treatment option for colon cancer for a selected group of patients.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Kim CW, Yang SY, Hur H, et al. Long-term oncologic outcomes of single-incision laparoscopic surgery for colon cancer. Surg Endosc. 2021. PMID: 34463871. doi:10.1007/s00464-021-08629-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。